×
About 16,970 results

ALLMedicine™ Hypoglycemia Center

Research & Reviews  5,248 results

Early Transient Hypoglycemia and Test Performance in At-Risk Newborns.
https://doi.org/10.1055/s-0041-1732380
American Journal of Perinatology; ElHassan NO, Schaefer EW et. al.

Aug 1st, 2021 - This study aimed to evaluate if early (within the first 3 hours after birth) transient neonatal hypoglycemia (TNH) is associated with poor academic performance in infants at-risk for hypoglycemia. This was a retrospective cohort study of at risk-i...

Clinical interpretation of the flash continuous glucose monitoring data out of range in...
https://doi.org/10.1016/j.diabres.2021.108989
Diabetes Research and Clinical Practice; Wen X, Ou T et. al.

Aug 1st, 2021 - Flash continuous glucose monitoring system (FCGM) reports nocturnal hypoglycemia with low accuracy in low blood glucose. In our study, we aimed to evaluate the accuracy and clinic profile of FCGM data out of range in T2DM. FCGM data out of range w...

Leptin receptor signaling is required for intact hypoglycemic counterregulation: A stud...
https://doi.org/10.1016/j.jdiacomp.2021.107994
Journal of Diabetes and Its Complications; Morrison CD, DuVall MA et. al.

Jul 31st, 2021 - Hypoglycemia is a major barrier to clinical management of persons with diabetes. Emerging evidence supports a role for leptin in gating hypoglycemic counterregulation. This work demonstrates that male leptin receptor null, Zucker (fa/fa), rats dis...

Hypoglycemia as a cause of sudden cardiac arrest during cesarean delivery under spinal ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320159
Journal of Medical Case Reports; Tilahun T, Gudina G

Jul 30th, 2021 - Sudden cardiac arrest during spinal anesthesia is a rare event. However, its management by an unprepared team is difficult and carries poor outcomes. Hypoglycemia as the cause of sudden cardiac arrest is rarely reported. This case illustrates life...

Angiotensin-Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues ...
https://doi.org/10.1002/cpt.2377
Clinical Pharmacology and Therapeutics; Nam YH, Brensinger CM et. al.

Jul 28th, 2021 - Serious hypoglycemia is a major adverse event associated with insulin secretagogues. Previous studies have suggested a potential relationship between angiotensin-converting enzyme inhibitors (ACEIs) used with sulfonylureas and serious hypoglycemia...

see more →

Guidelines  8 results

Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 19th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...

Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement ...
https://doi.org/10.1016/j.numecd.2019.07.017
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Pugliese G, Penno G et. al.

Oct 7th, 2019 - This joint document of the Italian Diabetes Society and the Italian Society of Nephrology reviews the natural history of diabetic kidney disease (DKD) in the light of the recent epidemiological literature and provides updated recommendations on an...

Identification and Management of Neonatal Hypoglycemia in the Full-Term Infant. British...
https://doi.org/10.1177/0890334419846128
Journal of Human Lactation : Official Journal of Internat... Hawdon JM

May 6th, 2019 - Identification and Management of Neonatal Hypoglycemia in the Full-Term Infant. British Association of Perinatal Medicine Framework for Practice, 2017.|2019|Hawdon JM,|prevention & control,prevention & control,standards,

Choosing Wisely in pediatric anesthesia: An interpretation from the German Scientific W...
https://doi.org/10.1111/pan.13383
Paediatric Anaesthesia; Becke K, Eich C et. al.

Jun 1st, 2018 - Inspired by the Choosing Wisely initiative, a group of pediatric anesthesiologists representing the German Working Group on Paediatric Anaesthesia (WAKKA) coined and agreed upon 10 concise positive ("dos") or negative ("don'ts") evidence-based rec...

Treatment of Type 2 Diabetes: From "Guidelines" to "Position Statements" and Back: Reco...
https://doi.org/10.2337/dcS15-3003
Diabetes Care; Mosenzon O, Pollack R et. al.

Jul 22nd, 2016 - Given the increased prevalence of type 2 diabetes worldwide, most patients are treated by their primary health care team (PHCT). PHCTs need guidance in choosing the best treatment regimen for patients, since the number of glucose-lowering agents (...

see more →

Drugs  195 results see all →

Clinicaltrials.gov  379 results

Glucose Time-In-Range Development Evaluation
https://clinicaltrials.gov/ct2/show/NCT03670017

May 7th, 2020 - Hyperglycemia, hypoglycemia and glycemic variability are independently associated with morbidity and mortality of critically ill patients. Blood glucose control with insulin has the potential to decrease morbidity and mortality of intensive care u...

Diagnosing and Treating Low Blood Sugar Levels
https://clinicaltrials.gov/ct2/show/NCT00001276

May 5th, 2020 - The purpose of this protocol is to continue our studies of the evaluation and treatment of patients with fasting hypoglycemia due to diverse etiologies. Patients will be admitted to the Clinical Research Center under this protocol and undergo supe...

Liver Glycogen and Hypoglycemia in Humans
https://clinicaltrials.gov/ct2/show/NCT03241706

May 5th, 2020 - There is universal agreement that iatrogenic hypoglycemia is the single most prominent barrier to the safe, effective management of blood sugar in people with type 1 diabetes (T1D). The typical patient with T1D is required to "count" the number of...

A Trial Comparing Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT03336528

May 4th, 2020 - Several outpatient trials have reported that treatment with degludec results in comparable improvement in HbA1c levels and in lower rates of hypoglycemia compared to glargine U100 insulin. However, no previous studies have compared the safety and ...

Impact of Hypoglycemia Unawareness on Brain Metabolism Cognition in T1DM
https://clinicaltrials.gov/ct2/show/NCT00575783

Apr 2nd, 2020 - During the course of treating diabetes (for example, after an insulin injection), blood sugar levels will sometimes drop too low. This condition is known as hypoglycemia. Normally, a healthy body responds to hypoglycemia by producing a number of "...

see more →

News  935 results

Nocturnal Hypoglycemia Halved With Insulin Degludec vs Glargine, Confirms Study in Type 1 Diabetes
https://www.medscape.com/viewarticle/954268

Jul 6th, 2021 - Patients with type 1 diabetes who used insulin degludec as their basal insulin had fewer than half the number of nocturnal hypoglycemia events, compared with patients who used insulin glargine U100, in a head-to-head crossover study with 51 patien...

Implanted Glucose Monitor for Diabetes Accurate Up to 6 Months
https://www.medscape.com/viewarticle/953860

Jun 28th, 2021 - A next-generation implanted continuous glucose monitor (Eversense, Senseonics/Ascensia) is accurate and safe for up to 6 months of use, new data suggest. The first-generation 90-day Eversense was approved by the US Food and Drug Administration in ...

Fast Five Quiz: Type 2 Diabetes Incretin-Based Therapy
https://reference.medscape.com/viewarticle/951449

Jun 24th, 2021 - Incretin-based agents were introduced into the diabetes treatment landscape to address postprandial glucose control. In the postprandial phase, nutrients are ingested; in response, incretins, such as glucagon-like peptide 1 (GLP-1) and gastric inh...

Fast Five Quiz: Type 2 Diabetes Incretin-Based Therapy
https://www.medscape.com/viewarticle/951449

Jun 24th, 2021 - Incretin-based agents were introduced into the diabetes treatment landscape to address postprandial glucose control. In the postprandial phase, nutrients are ingested; in response, incretins, such as glucagon-like peptide 1 (GLP-1) and gastric inh...

Hypoglycemia, Hypertension Tied to Cognitive Decline in Type 1 Diabetes
https://www.medscape.com/viewarticle/952990

Jun 14th, 2021 - NEW YORK (Reuters Health) - Patients with type 1 diabetes may be at greater risk of cognitive decline as they age, especially if they have high blood sugar, bouts of severe hypoglycemia and/or high blood pressure, researchers say. For individuals ...

see more →

Patient Education  23 results see all →